Glass half full approach in a very tough and evolving environment. Apart from finding the bright opportunity to acquire or merge with not sure what else they can be doing.
Positives are that Corum is still operationally making an underlying profit of $400K, still has a substantial cash bucket and is wisely investing in new innovative products and technology.
In the current environment the other smaller less financial companies must be feeling the pinch too; losing pricing power, margins and inability to fund investment in innovation. In Australia, there are obviously far too many companies in this pharmacy software and business services space so there has to be consolidation...... it's not rocket science. It will happen sooner or later as companies fail. Hopefully Corum can advantageously merge with or pick up some of the distressed businesses cheaply
Corum does have the financial strength and game plan to be one of the survivors.
COO Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held
